Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$47.45 -1.09 (-2.25%)
As of: Aug 20, 2026 · 3:59 PM EDT

Supernus Pharmaceuticals (SUPN) Receivables - Other (2012 - 2026)

Supernus Pharmaceuticals (SUPN) posted quarterly Receivables - Other of $4.3 million for Q2 2026, down 20.37% year-over-year from $5.4 million in Q2 2025, and up 126.32% on a QoQ basis from $1.9 million in Q1 2026.

Supernus Pharmaceuticals (SUPN) Receivables - Other (2012 - 2026) Analysis & Trends

Supernus Pharmaceuticals has reported Receivables - Other for 6 years, with the latest figure at $4.3 million in Q2 2026.

  • Receivables - Other for Q2 2026 came in at $4.3 million, down 20.37% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.3 million (down 20.37% YoY), and the FY2025 annual result was $1.8 million, down 55.0% from the prior year.
  • Receivables - Other improved to $4.3 million in Q2 2026, from $1.9 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $6.3 million in Q3 2025 and troughed at $1.8 million in Q4 2025.
  • A 3-year average of $4.0 million and a median of $4.1 million in 2024 frame the typical range for Receivables - Other.
  • The widest annual swing landed in 2025, when Receivables - Other tumbled 55.0%; it then declined 20.37% in 2026.
  • A 3-year view of Receivables - Other shows it stood at $4.0 million in 2024, then tumbled by 55.0% to $1.8 million in 2025, then soared by 138.89% to $4.3 million in 2026.
  • Per Business Quant data, the three most recent Receivables - Other figures were $4.3 million in Q2 2026, $1.9 million in Q1 2026, and $1.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Supernus Pharmaceuticals 2.75 Bn 2.38 Bn 185.39 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.30 Mn
Jun 30, 2026 4.30 Mn
Mar 31, 2026 1.90 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2025 1.80 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 6.30 Mn
Sep 30, 2025 6.30 Mn
Jun 30, 2025 5.40 Mn
Jun 30, 2025 5.40 Mn
Dec 31, 2024 4.00 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2014 493,000.00
Sep 30, 2014 493,000.00
Jun 30, 2014 496,000.00
Jun 30, 2014 496,000.00
Mar 31, 2014 636,000.00
Mar 31, 2014 636,000.00
Dec 31, 2013 483,000.00
Dec 31, 2013 483,000.00